The original claim was that CYDY wanted 4 doses fo
Post# of 148264
The PR talks about what they learned after CD12 was complete, that LL subjects were dying after 2 weeks, that survival was excellent vs. Placebo at 14 days. The part you highlighted is talking about the next trials, CD16. They want to go from to to 4 like they originally proposed. It doesn't say they originally submitted CD12 as just 2 doses.
Unless I am confused about what you are arguing?